Weill Cornell's strategic plan to enhance its educational, research and clinical programs is paying dividends as reflected in the latest rankings of the leading research medical schools published in U.S.News & World Report's annual survey of graduate education (April 9, 2001).
Weill Cornell's overall score went from 54 (last year) to 80putting Weill Cornell in a three-way tie for 11th place, with Baylor College of Medicine and the University of Washington. Last year, Weill Cornell ranked 14th.
Weill Cornell has risen significantly in total research funding received from the NIH: $125.4 million in 1998, $133.4 million in 1999, and $153.5 million in 2000. Also increasing significantly was the student-selectivity ranking.
Weill Medical College also ranked among the top medical schools in the U.S. for primary carewith 51.3 percent of its graduates over the last three years going into primary-care specialties. Weill Cornell was the only medical school in New York City that was ranked among the leading medical schools in both the research and primary-care categories.
"The objective of our strategic planning, which is an ongoing process, is to give Weill Cornell the faculty, students, staff, laboratories, facilities and clinics that it will need to keep moving forward among the leading medical schools in the U.S.," said Weill Cornell dean, Dr. Antonio Gotto. "Obviously, substantial resources will be required to accomplish all of our objectives. We are extremely pleased with our results so farand look forward to even better results in the coming years when we have fully implemented our Strategic Plan for Research and introduced a new phase to 'Advance the Clinical Mission.'"